We are pleased to announce that Allergy Free Restaurants Ltd, which has developed a mobile app that allows users to select restaurants chains and dishes based upon their individual dietary requirements, has now joined the Deepbridge Life Sciences EIS portfolio.
This follows on from an initial seed funding round earlier in the year, through the Deepbridge Life Sciences SEIS portfolio.
We are pleased to announce that Flex-G Pty Ltd, which was established to exploits water-based nanofluids for engine cooling, has joined the Deepbridge Technology Growth EIS portfolio.
A total target raise of up to £1.65m was recently agreed, which will be used for product development, user testing, expanding their facilities and test/production equipment.
We are pleased to announce that Saltee Skincare Ltd, which was founded to create a luxurious, clean and quality sun protection, has now joined the Deepbridge Life Sciences EIS portfolio.
This follows on from an initial seed funding round earlier in the year, through the Deepbridge Life Sciences SEIS portfolio.
Deepbridge are pleased to announce the appointment of two new members to the team, Francesca Eastwood and Ellie Thomas.
We are pleased to announce that Property Innovation Network Ltd, which is developing a 'property and life manager' platform, has now joined the Deepbridge Technology Growth EIS portfolio.
This follows on from initial seed funding round earlier in the year, through the Deepbridge Innovation SEIS portfolio.
We are pleased to announce that Playback Live Ltd, which seeks to develop and implement a business model based on the rental of activity cameras within the content of an 'experience platform', has now joined the Deepbridge Technology Growth EIS portfolio.
This follows on from an initial seed funding round earlier in the year, through the Deepbridge Innovation SEIS portfolio.
Ian Warwick (Managing Partner, Deepbridge) and Savvas Neophytou (Partner & Head of Life Sciences, Deepbridge) recently spoke with GBI Magazine about a range of topics, including the technology and life sciences sectors, as well as the key criteria Deepbridge looks for in investee companies.
